Adam Frymoyer

Publication Details

  • Prevalence of Acid-Reducing Agents (ARA) in Cancer Populations and ARA Drug-Drug Interaction Potential for Molecular Targeted Agents in Clinical Development MOLECULAR PHARMACEUTICS Smelick, G. S., Heffron, T. P., Chu, L., Dean, B., West, D. A., DuVall, S. L., Lum, B. L., Budha, N., Holden, S. N., Benet, L. Z., Frymoyer, A., Dresser, M. J., Waret, J. A. 2013; 10 (11): 4055-4062

    View details for DOI 10.1021/mp400403s

    View details for Web of Science ID 000326669400012

Stanford Medicine Resources:

Footer Links: